Related Experiment Video
Updated: Jun 16, 2026
05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
Targeted molecular therapies in thyroid carcinoma
Serena Romagnoli1, Sonia Moretti, Pasquale Voce
1Department of Internal Medicine, University of Perugia, Perugia, Italy.
Arquivos Brasileiros De Endocrinologia E Metabologia
|February 4, 2010
Summary
Thyroid cancer treatments are improving with new targeted therapies. Small-molecule tyrosine kinase inhibitors show promise for advanced thyroid cancers, offering new hope for patients with persistent or recurrent disease.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Thyroid cancer incidence has risen significantly over the past 30 years.
- Differentiated thyroid carcinomas (DTC) have a good prognosis, but 15% recur.
- Medullary thyroid carcinoma and advanced thyroid cancers have poor prognoses with limited treatment options.
Purpose of the Study:
- To review the molecular basis of thyroid cancer.
- To explore novel therapeutic strategies for thyroid cancer.
- To evaluate the efficacy of small-molecule tyrosine kinase inhibitors in thyroid cancer treatment.
Main Methods:
- Review of molecular events in thyroid cancer pathogenesis.
- Analysis of clinical trial data for targeted therapies.
- Evaluation of small-molecule tyrosine kinase inhibitors.
Main Results:
- Understanding of molecular pathways has led to new treatments.
- Small-molecule tyrosine kinase inhibitors have shown promising results in clinical trials.
- These inhibitors are being investigated for locally advanced or metastatic thyroid carcinomas.
Conclusions:
- Novel targeted therapies, particularly tyrosine kinase inhibitors, represent a promising advancement in thyroid cancer treatment.
- These molecularly targeted drugs offer new hope for patients with advanced or refractory thyroid cancer.
- Further clinical investigation is warranted to establish the role of these inhibitors in managing thyroid cancer.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:20Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...